Sign In
Buy ENTA
Enanta Pharmaceuticals Stock Insider Power
Based on the 100 latest insides trades, we have calculated the insider power to be positive at 88.69. In total, the insiders bought 1.39M and sold 42.79K ENTA shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.
Insider Power
|
88.69 |
| ● Buy | 1.39M shares |
| ● Sell | 42.79K shares |
|
77% Buy Activity
Negligible or No Correlation
|
|
Historical Insider Trades
| Date | Type | Person | Role | Amount |
|---|---|---|---|---|
|
Dec 05, 2025 Sell |
Kieffer Tara Lynn Chief Product Strategy Officer |
2 106 Value: $30.0K |
||
|
Dec 05, 2025 Sell |
Rottinghaus Scott T. Chief Medical Officer |
798 Value: $11.4K |
||
|
Dec 05, 2025 Sell |
Capps Kathleen S. See Remarks |
323 Value: $5K |
||
|
Dec 05, 2025 Sell |
Trout Harry R. Iii See Remarks |
542 Value: $8K |
||
|
Dec 05, 2025 Sell |
Luu Brendan Chief Business Officer |
1 394 Value: $19.8K |
||
|
Dec 05, 2025 Sell |
Or Yat Sun Chief Scientific Officer |
2 390 Value: $34.0K |
||
|
Dec 02, 2025 Sell |
Trout Harry R. Iii See Remarks |
380 Value: $5K |
||
|
Dec 02, 2025 Sell |
Capps Kathleen S. See Remarks |
207 Value: $3K |
||
|
Dec 01, 2025 Sell |
Or Yat Sun Chief Scientific Officer |
753 Value: $10.6K |
||
|
Dec 01, 2025 Sell |
Capps Kathleen S. See Remarks |
85 Value: $1K |
||
|
Dec 01, 2025 Sell |
Trout Harry R. Iii See Remarks |
105 Value: $1K |
||
|
Dec 01, 2025 Sell |
Luu Brendan Chief Business Officer |
498 Value: $7K |
||
|
Dec 01, 2025 Sell |
Kieffer Tara Lynn Chief Product Strategy Officer |
753 Value: $10.6K |
||
|
Dec 01, 2025 Sell |
Luly Jay R. President And CEO |
1 885 Value: $26.6K |
||
|
Nov 25, 2025 Buy |
Luly Jay R. President And CEO |
310 000 Value: $4.23M |
||
|
Nov 25, 2025 Buy |
Kowalsky Matthew Paul Chief Legal Officer |
90 000 Value: $1.23M |
||
|
Nov 25, 2025 Buy |
Luu Brendan Chief Business Officer |
90 000 Value: $1.23M |
||
|
Nov 25, 2025 Buy |
Trout Harry R. Iii See Remarks |
6 463 Value: $88.3K |
||
|
Nov 25, 2025 Buy |
Capps Kathleen S. See Remarks |
6 325 Value: $86.4K |
||
|
Nov 25, 2025 Buy |
Capps Kathleen S. See Remarks |
3 163 Value: $43.2K |
||
|
Nov 25, 2025 Buy |
Trout Harry R. Iii See Remarks |
12 925 Value: $176.6K |
||
|
Nov 25, 2025 Buy |
Kieffer Tara Lynn Chief Product Strategy Officer |
100 000 Value: $1.37M |
||
|
Nov 25, 2025 Buy |
Rottinghaus Scott T. Chief Medical Officer |
110 000 Value: $1.50M |
||
|
Nov 25, 2025 Buy |
Or Yat Sun Chief Scientific Officer |
110 000 Value: $1.50M |
||
|
Aug 26, 2025 Buy |
Capps Kathleen S. See Remarks |
0 Value: $0 |
About Insider Power
Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.
It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.
While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.
* October 6th, 2025 - Tested on 5562 stocks
